Meeder Advisory Services’s Moderna MRNA Stock Holding History

Meeder Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Sell	7,734 -384	-5%	-$19.9K	0.02%	406
2026 Q1	$412K	Buy	8,118 +904	+13%	+$42.2K	0.02%	437
2025 Q4	$213K	Buy	+7,214	New	+$196K	0.01%	631
2024 Q3	–	Sell	-3,447	Closed	-$409K	–	564
2024 Q2	$409K	Buy	3,447 +1,516	+79%	+$192K	0.03%	354
2024 Q1	$206K	Buy	+1,931	New	+$195K	0.02%	430
2023 Q4	–	Sell	-1,997	Closed	-$206K	–	435
2023 Q3	$206K	Sell	1,997 -1,372	-41%	-$153K	0.03%	392
2023 Q2	$409K	Sell	3,369 -825	-20%	-$110K	0.04%	310
2023 Q1	$644K	Buy	4,194 +166	+4%	+$27.4K	0.07%	235
2022 Q4	$724K	Buy	+4,028	New	+$659K	0.09%	206

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Meeder Advisory Services's MRNA Position: Q2 2026 in Review

Meeder Advisory Services reduced its Moderna (MRNA) stake by 4.7% in Q2 2026, selling an estimated $19.9K and leaving 7,734 shares worth $542K. The position accounts for 0.02% of the portfolio, ranked #406.

Meeder Advisory Services first reported a position in MRNA in Q4 2022 and has held it in 9 quarters since. The position peaked at $724K in Q4 2022. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Meeder Advisory Services held 7,734 shares of Moderna worth $542K as of Q2 2026.
Meeder Advisory Services sold 384 Moderna shares in Q2 2026, an estimated $19.9K.
Moderna made up 0.02% of Meeder Advisory Services's portfolio in Q2 2026, its #406 holding.
Meeder Advisory Services first reported a position in Moderna in Q4 2022 and has held it in 9 quarters since.
Meeder Advisory Services's Moderna position peaked at $724K in Q4 2022.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.